Paying attention

Ebb & Flow

Two U.K. companies are moving onto the London Stock Exchange this week in the hopes of capturing the attention of tech-oriented institutional investors. Antisoma(EASD:ASOM; LSE:ASM), which develops cancer therapies, is added a listing on LSE to its EASDAQ presence. SR Pharma (LSE:SPA), specializing in cancer and asthma, will graduate from the Alternative Investment Market (AIM), to the main exchange. ...